NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-07, Vol.30, p.iv80-iv80 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | iv80 |
|---|---|
| container_issue | |
| container_start_page | iv80 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Weinberg, B. Renouf, D. Lim, H. Heining, C. Schlenk, R. Jones, M. Liu, S. Cseh, A. Solca, F. Laskin, J. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz155.290 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz155_290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419308075</els_id><sourcerecordid>S0923753419308075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2780-4a616c1a9593124b0e3fa97dd365681216d85327719403b7c14a3b6fec2554883</originalsourceid><addsrcrecordid>eNp9kM1KxDAURoMozjj6AG6kL9CZ_LfRlYiOwqAgupSQpqlEpklJ0gF9ejNUXbq63Mt3Pi4HgHMElwgKslLOeadXffuFGFtiAQ_AHDEuyhpSdAjmUGBSVozQGTiJ8QNCyAUWx2BGMKwZgXQO3h6f16jsxmi9KwYfbbI7U7yrmIK3LpmYrFPbIo29H0O8LFSn8sU2hYqFKpzfmW3GknHJ7mPBqNTnpfBDyo2n4KhT22jOfuYCvN7dvtzcl5un9cPN9abUuKphSRVHXCMlmCAI0wYa0ilRtS3hjNcII97md3FVIUEhaSqNqCIN74zGjNG6JguApl4dfIzBdHIItlfhUyIo96rkpEpOqmRWlZmLiRnGpjftH_HrJgeupoDJn--sCTJqa5w2rQ1GJ9l6-0_9N6_ufJ0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Weinberg, B. ; Renouf, D. ; Lim, H. ; Heining, C. ; Schlenk, R. ; Jones, M. ; Liu, S. ; Cseh, A. ; Solca, F. ; Laskin, J.</creator><creatorcontrib>Weinberg, B. ; Renouf, D. ; Lim, H. ; Heining, C. ; Schlenk, R. ; Jones, M. ; Liu, S. ; Cseh, A. ; Solca, F. ; Laskin, J.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdz155.290</identifier><identifier>PMID: 32085304</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2019-07, Vol.30, p.iv80-iv80</ispartof><rights>2019 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2780-4a616c1a9593124b0e3fa97dd365681216d85327719403b7c14a3b6fec2554883</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32085304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weinberg, B.</creatorcontrib><creatorcontrib>Renouf, D.</creatorcontrib><creatorcontrib>Lim, H.</creatorcontrib><creatorcontrib>Heining, C.</creatorcontrib><creatorcontrib>Schlenk, R.</creatorcontrib><creatorcontrib>Jones, M.</creatorcontrib><creatorcontrib>Liu, S.</creatorcontrib><creatorcontrib>Cseh, A.</creatorcontrib><creatorcontrib>Solca, F.</creatorcontrib><creatorcontrib>Laskin, J.</creatorcontrib><title>NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kM1KxDAURoMozjj6AG6kL9CZ_LfRlYiOwqAgupSQpqlEpklJ0gF9ejNUXbq63Mt3Pi4HgHMElwgKslLOeadXffuFGFtiAQ_AHDEuyhpSdAjmUGBSVozQGTiJ8QNCyAUWx2BGMKwZgXQO3h6f16jsxmi9KwYfbbI7U7yrmIK3LpmYrFPbIo29H0O8LFSn8sU2hYqFKpzfmW3GknHJ7mPBqNTnpfBDyo2n4KhT22jOfuYCvN7dvtzcl5un9cPN9abUuKphSRVHXCMlmCAI0wYa0ilRtS3hjNcII97md3FVIUEhaSqNqCIN74zGjNG6JguApl4dfIzBdHIItlfhUyIo96rkpEpOqmRWlZmLiRnGpjftH_HrJgeupoDJn--sCTJqa5w2rQ1GJ9l6-0_9N6_ufJ0</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Weinberg, B.</creator><creator>Renouf, D.</creator><creator>Lim, H.</creator><creator>Heining, C.</creator><creator>Schlenk, R.</creator><creator>Jones, M.</creator><creator>Liu, S.</creator><creator>Cseh, A.</creator><creator>Solca, F.</creator><creator>Laskin, J.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201907</creationdate><title>NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option</title><author>Weinberg, B. ; Renouf, D. ; Lim, H. ; Heining, C. ; Schlenk, R. ; Jones, M. ; Liu, S. ; Cseh, A. ; Solca, F. ; Laskin, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2780-4a616c1a9593124b0e3fa97dd365681216d85327719403b7c14a3b6fec2554883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weinberg, B.</creatorcontrib><creatorcontrib>Renouf, D.</creatorcontrib><creatorcontrib>Lim, H.</creatorcontrib><creatorcontrib>Heining, C.</creatorcontrib><creatorcontrib>Schlenk, R.</creatorcontrib><creatorcontrib>Jones, M.</creatorcontrib><creatorcontrib>Liu, S.</creatorcontrib><creatorcontrib>Cseh, A.</creatorcontrib><creatorcontrib>Solca, F.</creatorcontrib><creatorcontrib>Laskin, J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weinberg, B.</au><au>Renouf, D.</au><au>Lim, H.</au><au>Heining, C.</au><au>Schlenk, R.</au><au>Jones, M.</au><au>Liu, S.</au><au>Cseh, A.</au><au>Solca, F.</au><au>Laskin, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>30</volume><spage>iv80</spage><epage>iv80</epage><pages>iv80-iv80</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32085304</pmid><doi>10.1093/annonc/mdz155.290</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-07, Vol.30, p.iv80-iv80 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz155_290 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A21%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NRG1-fusion%20positive%20gastrointestinal%20tumours:%20afatinib%20as%20a%20novel%20potential%20treatment%20option&rft.jtitle=Annals%20of%20oncology&rft.au=Weinberg,%20B.&rft.date=2019-07&rft.volume=30&rft.spage=iv80&rft.epage=iv80&rft.pages=iv80-iv80&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdz155.290&rft_dat=%3Celsevier_cross%3ES0923753419308075%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32085304&rft_els_id=S0923753419308075&rfr_iscdi=true |